ZA200705113B
(en )
2009-12-30
Solid dosage form comprising proton pump inhibitor and suspension made thereof
NO2022022I1
(en )
2022-06-09
Fedratinib, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate thereof, in particular fedratinib dihydrochloride monohydrate
EP1803709A4
(en )
2009-11-04
Proton pump inhibitors
IL180078A
(en )
2014-01-30
9-cis-retinal derivative for use in the treatment of 11-cis -retinal deficiency
IL173490A0
(en )
2006-06-11
4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
PL372814A1
(en )
2005-08-08
Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
IL183101A
(en )
2015-04-30
Use of tetrahydrocannabivarin in the manufacture of medicaments
IL192053A
(en )
2014-01-30
2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors and the use thereof in the preparation of medicaments
EP1731547A4
(en )
2007-05-09
Polymerizable compounds and use thereof
IL182261A0
(en )
2007-07-24
Therapeutic agents with decreased toxicity
IL190284A
(en )
2014-01-30
Use of milnacipran or pharmaceutically acceptable salt thereof in the preparation of a medicament for treating fibromyalgia
IL172694A0
(en )
2006-04-10
6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
GB0324761D0
(en )
2003-11-26
Use of compounds in therapy
HK1099757A1
(en )
2007-08-24
Caspase inhibitors and uses thereof
ZA200703478B
(en )
2008-07-30
Therapeutic agents with decreased toxicity
EP1614719A4
(en )
2008-06-11
Azo compound and salt thereof
HK1197065A1
(en )
2015-01-02
New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
IL185729A0
(en )
2008-01-06
Crystallization inhibitor and its use in gelatin capsules
AU2003293998A1
(en )
2004-11-04
Use of alkyl resorcinols in the treatment of acne
AP2007004052A0
(en )
2007-06-30
Use of surfactants in the production of metal
PL1940818T3
(en )
2012-01-31
Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
AP2006003703A0
(en )
2006-08-31
Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
EP1757282A4
(en )
2010-02-10
The use of kauranes compounds in the manufacture of medicament
EP1786415A4
(en )
2010-01-20
Metabolism-modulating agents and uses therefor
PL1651217T3
(en )
2008-07-31
Alkaline salts of proton pump inhibitors